#hims--hers

[ follow ]
#telehealth
Healthcare
fromFast Company
2 months ago

Hims & Hers stock surges 23%: Telehealth company announces expansion into blood testing weeks after Super Bowl buzz

Hims & Hers is expanding into at-home blood testing to enhance personal healthcare through technology.
NYC startup
fromSFGATE
2 months ago

Bay Area startup, a few years after being bought for $131M, shuts down

Apostrophe is shutting down to streamline dermatology services under Hims & Hers.
Miscellaneous
fromFast Company
3 months ago

Hims & Hers markets itself in a very 2025 way: by picking a fight

Hims & Hers targets Big Pharma with a Super Bowl ad promoting a cheaper weight-loss drug, reflecting anti-establishment sentiments.
Healthcare
fromFast Company
2 months ago

Hims & Hers stock surges 23%: Telehealth company announces expansion into blood testing weeks after Super Bowl buzz

Hims & Hers is expanding into at-home blood testing to enhance personal healthcare through technology.
NYC startup
fromSFGATE
2 months ago

Bay Area startup, a few years after being bought for $131M, shuts down

Apostrophe is shutting down to streamline dermatology services under Hims & Hers.
Miscellaneous
fromFast Company
3 months ago

Hims & Hers markets itself in a very 2025 way: by picking a fight

Hims & Hers targets Big Pharma with a Super Bowl ad promoting a cheaper weight-loss drug, reflecting anti-establishment sentiments.
#stock-market
Growth hacking
from24/7 Wall St.
2 months ago

HIMS Stock Craters - Is It a Buying Opportunity?

Hims & Hers Health faces challenges after the FDA resolved the semaglutide shortage, impacting their growth from compounding drug sales.
Growth hacking
from24/7 Wall St.
2 months ago

HIMS Stock Craters - Is It a Buying Opportunity?

Hims & Hers Health faces challenges after the FDA resolved the semaglutide shortage, impacting their growth from compounding drug sales.
[ Load more ]